Decision framework for chemical process design including different stages of environmental, health, and safety assessment H Sugiyama, U Fischer, K Hungerbühler, M Hirao AIChE Journal 54 (4), 1037-1053, 2008 | 174 | 2008 |
Using standard statistics to consider uncertainty in industry-based life cycle inventory databases H Sugiyama, Y Fukushima, M Hirao, S Hellweg, K Hungerbühler The International Journal of Life Cycle Assessment 10 (6), 399-405, 2005 | 89 | 2005 |
Comparison of methods for assessing environmental, health and safety (EHS) hazards in early phases of chemical process design IK Adu, H Sugiyama, U Fischer, K Hungerbühler Process Safety and Environmental Protection 86 (2), 77-93, 2008 | 88 | 2008 |
Decision support method for the choice between batch and continuous technologies in solid drug product manufacturing K Matsunami, T Miyano, H Arai, H Nakagawa, M Hirao, H Sugiyama Industrial & Engineering Chemistry Research 57 (30), 9798-9809, 2018 | 60 | 2018 |
A hierarchical activity model of chemical process design based on life cycle assessment H Sugiyama, M Hirao, R Mendivil, U Fischer, K Hungerbühler Process Safety and Environmental Protection 84 (1), 63-74, 2006 | 56 | 2006 |
Framework for analyzing the effects of packaging on food loss reduction by considering consumer behavior N Yokokawa, E Kikuchi-Uehara, H Sugiyama, M Hirao Journal of cleaner production 174, 26-34, 2018 | 55 | 2018 |
Environmental potential of reusing, renting, and sharing consumer products: Systematic analysis approach E Amasawa, T Shibata, H Sugiyama, M Hirao Journal of Cleaner Production 242, 118487, 2020 | 53 | 2020 |
Designing interventions for behavioral shifts toward product sharing: The case of laundry activities in Japan E Amasawa, Y Suzuki, D Moon, J Nakatani, H Sugiyama, M Hirao Sustainability 10 (8), 2687, 2018 | 51 | 2018 |
A large-scale experimental comparison of batch and continuous technologies in pharmaceutical tablet manufacturing using ethenzamide K Matsunami, T Nagato, K Hasegawa, H Sugiyama International journal of pharmaceutics 559, 210-219, 2019 | 40 | 2019 |
Improving lead time of pharmaceutical production processes using Monte Carlo simulation LG Eberle, H Sugiyama, R Schmidt Computers & chemical engineering 68, 255-263, 2014 | 40 | 2014 |
Activity modeling for integrating environmental, health and safety (EHS) consideration as a new element in industrial chemical process design H Sugiyama, M Hirao, U Fischer, K Hungerbühler Journal of Chemical Engineering of Japan 41 (9), 884-897, 2008 | 39 | 2008 |
Techno‐economic and environmental assessment of bioethanol‐based chemical process: A case study on ethyl acetate NT Hong Thuy, Y Kikuchi, H Sugiyama, M Noda, M Hirao Environmental progress & sustainable energy 30 (4), 675-684, 2011 | 35 | 2011 |
Integrated design of biopharmaceutical manufacturing processes: Operation modes and process configurations for monoclonal antibody production S Badr, K Okamura, N Takahashi, V Ubbenjans, H Shirahata, H Sugiyama Computers & Chemical Engineering 153, 107422, 2021 | 32 | 2021 |
Demonstrating multi-objective screening of chemical batch process alternatives during early design phases T Albrecht, S Papadokonstantakis, H Sugiyama, K Hungerbühler Chemical Engineering Research and Design 88 (5-6), 529-550, 2010 | 31 | 2010 |
A PSE perspective for the efficient production of monoclonal antibodies: integration of process, cell, and product design aspects S Badr, H Sugiyama Current Opinion in Chemical Engineering 27, 121-128, 2020 | 30 | 2020 |
Design of recycling system for poly (methyl methacrylate)(PMMA). Part 2: process hazards and material flow analysis Y Kikuchi, M Hirao, H Sugiyama, S Papadokonstantakis, K Hungerbühler, ... The International Journal of Life Cycle Assessment 19, 307-319, 2014 | 29 | 2014 |
Dynamic modelling, simulation and economic evaluation of two CHO cell-based production modes towards developing biopharmaceutical manufacturing processes H Shirahata, S Diab, H Sugiyama, DI Gerogiorgis Chemical Engineering Research and Design 150, 218-233, 2019 | 27 | 2019 |
Determining key parameters of continuous wet granulation for tablet quality and productivity: A case in ethenzamide K Matsunami, T Nagato, K Hasegawa, H Sugiyama International Journal of Pharmaceutics 579, 119160, 2020 | 26 | 2020 |
Cost–benefit analysis of monoclonal antibody cultivation scenarios in terms of life cycle environmental impact and operating cost E Amasawa, H Kuroda, K Okamura, S Badr, H Sugiyama ACS Sustainable Chemistry & Engineering 9 (42), 14012-14021, 2021 | 25 | 2021 |
Rigorous approach to scheduling of sterile drug product manufacturing L Eberle, E Capón-García, H Sugiyama, A Graser, R Schmidt, ... Computers & Chemical Engineering 94, 221-234, 2016 | 24 | 2016 |